Table 2.
Population characteristics by HCV issues and gender
| Total (n=68) | Male (n= 50) | Female (n = 18) | P-Value | |
|---|---|---|---|---|
| Diagnosed hepatitis C (years) | 10.5 (8.0, 16.2) | 10.0 (7.7, 17.0) | 12.5 (9.0, 6.7) | 0.817 |
| Symptoms related to hepatitis C % (n) | 47.0 (32) | 42.0 (21) | 61.1 (11) | 0.172 |
| Offered OPD appointment % (n) | 57.3 (39) | 60.0 (30) | 50.0 (9) | 0.414 |
| Attend OPD appointment % (n) | 54.4 (37) | 54.0 (27) | 55.5 (10) | 0.906 |
| Previous liver biopsy or Fibroscan % (n) | 29.4 (20) | 32.0 (16) | 22.2 (4) | 0.348 |
| Fibroscan result (kPa) | 6.4 (5.2, 10.1) | 7.2 (5.3, 11.8) | 5.6 (5.2, 6.7) | 0.104 |
| Previously assessed suitable for treatment % (n) | 19.1 (13) | 26.0 (13) | 0 | 0.016 |
| Fibroscan result >8.55 (kPa) % (n) | 32.3 (22) | 38.0 (19) | 16.6 (3) | 0.072 |
| Fibroscan result >12.5 (kPa) % (n) | 20.3 (12) | 20.0 (10) | 11.1 (2) | 0.362 |
Values are median (25th–75th percentile) or % (n). Continuous variables assessed by independent T-test; Categorical variables assessed by Chi-square. HCV: hepatitis C virus. P<0.05 were considered statistically significant.